Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-03-01 00:00:00 ET · period of report 2022-02-25 · accession 0001127602-22-007459 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-01 | 2022-02-25 | TMO | Lagarde Michel | EVP, COO | F - Tax | $549.83 | -1,025 | 22.0K | -4% | -$563.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-25 | F | D | 1,025 | $549.83 | 21,978.21 | D | — | — |